Intracoronary Infusion of Mononuclear Bone Marrow-Derived Stem Cells is Associated with a Lower Plaque Burden After Four Years
Open Access
- 1 January 2014
- journal article
- research article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 21 (3) , 217-229
Abstract
Aim: To assess the long-term effects of intracoronary stem cell (SC) infusion following acute myocardial infarction (AMI) on the local atherosclerotic process at the site of infusion after four years of follow-up. Methods: We evaluated 18 post-AMI patients. Group 1 consisted of nine patients given an intracoronary injection of autologous mononuclear SC, and group 2 consisted of nine patients given a placebo injection. The plaque count, plaque burden (PB) and coronary calcium score (CCS) were assessed using multislice 64 CT angiography of the coronary tree four years after SC injection. Results: The total PB and CCS along the entire coronary segment distal to the site of infusion were significantly lower in the SC group (PB-702 mm3 vs. 1.465 mm3, p=0.0006; CCS-295 vs. 796, p< 0.0001).The mean PB per coronary artery was 112.12 mm3±16.82 mm3 for the treated arteries vs. 189.56 mm3±20.98 mm3 for the untreated arteries (p<0.0001), while the mean CCS was 53.12±16.4 vs. 106.43±10.86 (p<0.0001). In the SC group, there were significant differences in the mean PB (87.75 mm3 vs. 112.12 mm2, p= 0.005) and mean CCS (36.87 vs. 53.12, p=0.04) between the coronary segment infused with SC and the entire coronary artery. Conclusions: Multislice CT angiography of atheromatous plaques in the coronary tree four years after SC infusion in post-AMI patients indicates a significantly lower atheromatous plaque burden, as demonstrated by a lower plaque volume and lower CCS at the site of stem cell infusion compared with other coronary territories.Keywords
This publication has 24 references indexed in Scilit:
- Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with myocardial infarctionEuropean Heart Journal, 2012
- In Vivo Functional and Transcriptional Profiling of Bone Marrow Stem Cells After Transplantation Into Ischemic MyocardiumArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Molecular Imaging of Stem Cells: Tracking Survival, Biodistribution, Tumorigenicity, and ImmunogenicityTheranostics, 2012
- Mononuclear cell therapy attenuates atherosclerosis in apoE KO miceLipids in Health and Disease, 2011
- Reproducibility of coronary plaque detection and characterization using low radiation dose coronary computed tomographic angiography in patients with intermediate likelihood of coronary artery disease (ReSCAN study)The International Journal of Cardiovascular Imaging, 2011
- Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challengesEuropean Heart Journal, 2011
- Inhibited atherosclerotic plaque formation by local administration of magnetically labeled endothelial progenitor cells (EPCs) in a rabbit modelAtherosclerosis, 2009
- Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarctionAmerican Heart Journal, 2007
- The Effect of Stem Cell Mobilization by Granulocyte-Colony Stimulating Factor on Neointimal Hyperplasia and Endothelial Healing After Vascular Injury With Bare-Metal Versus Paclitaxel-Eluting StentsJACC, 2006
- Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-upInternational Journal of Cardiology, 2006